Skip to content

Involuntary Memories Investigation in Schizophrenia

Involuntary Memories Investigation in Schizophrenia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03209778
Enrollment
65
Registered
2017-07-06
Start date
2017-09-29
Completion date
2019-12-15
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

Patients with schizophrenia suffer from autobiographical memory disorders. Patients have difficulty to remember vividly personal past events when they are specifically asked for. Indeed, this task requires a good executive functioning to retrieve precise information stored in long term memory. Interestingly, executive functioning has been showed impaired in schizophrenia and studies showed that their autobiographical memory impairments were directed related to their executive dysfunction. Yet, in daily life people remember more often autobiographical memories spontaneously, without trying voluntarily to recall them. In that case, the involuntary recall of personal past events is much less sustained by executive functioning. In this protocol the investigators would like to investigate and compare subjective characteristics of involuntary and voluntary autobiographical memories in order to highlight the role of executive dysfunction in patients' autobiographical memory impairments.

Interventions

OTHERPatients with Schizophrenia

Patients with schizophrenia or schizoaffective disorder according to DSM-V criteria

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* \- for patients only * male or female * age limits : 18-55 years old * under the protection of health insurance * who have signed up the consent form * schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013). * clinically stable for at least 2 months * patients under guardianship or curatorship need agreement of their legal representative * informed of the results of prior medical examination for controls only * male or female * age limits : 18-55 years old * under the protection of health insurance * who have sign up the consent form * recruited from the general population and matched on gender, age years of schooling * no psychiatric history (DSM-5)

Exclusion criteria

* for both patients and controls * current severe or unstable somatic illness * neurological history (brain injury \> 15 minutes loss of consciousness , epilepsia, brain surgery…) * current substance use disorder (DSM-5) * current major depressive disorder (CDSS,BDI, HDRS) * mental retardation (IQ \< 70, WAIS-4, f-NART) * history of general anesthesia 3 months prior to the experiment * pregnancy declared by the subject * breast feeding * current legal control * in emergency situation * included during exclusion period in another experiment * for controls only * taking of antipsychotic drugs for the 3 weeks prior to inclusion * under guardianship or curatorship

Design outcomes

Primary

MeasureTime frame
Autobiographical subjective score taking into account memories vividness and specifity8 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026